Caroline Popper
Follow
Get notifications in MyBN when activity occurs.
Caroline Popper
Dr Caroline Popper has over 25 years of operational experience in the international diagnostics, medical devices and drug discovery fields.
After 10 years in senior management and marketing roles at Becton, Dickinson and Company, Dr Popper established her own consultancy company to provide strategic corporate and advisory services to businesses across the life sciences spectrum.
A qualified health economist, Dr Popper served in senior managerial and advisory positions with numerous global diagnostics and medical research companies including bioMerieux and MDS Proteomics, where she was chief business officer from 2000 to 2002. In addition to her corporate experience, she also enjoys a hands-on clinical perspective from her years as an attending physician at the Department of Emergency Medicine at Baltimore's Johns Hopkins Hospital, where she completed residencies in internal medicine and pathology.
After 10 years in senior management and marketing roles at Becton, Dickinson and Company, Dr Popper established her own consultancy company to provide strategic corporate and advisory services to businesses across the life sciences spectrum.
A qualified health economist, Dr Popper served in senior managerial and advisory positions with numerous global diagnostics and medical research companies including bioMerieux and MDS Proteomics, where she was chief business officer from 2000 to 2002. In addition to her corporate experience, she also enjoys a hands-on clinical perspective from her years as an attending physician at the Department of Emergency Medicine at Baltimore's Johns Hopkins Hospital, where she completed residencies in internal medicine and pathology.
Lists and Charts
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 96th | Land & Homes Group | 100% | 15% |
| 911th | Maximus Resources | -12% | -17% |
| 1552nd | Papyrus Australia | -55% | 7% |
| 1566th | LBT Innovations | -57% | -20% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 930th |  | LBT Innovations | $2.3m |
| 1121st | | Papyrus Australia | $98k |
| 1123rd | | Magellan Global Trust | $93k |
| 1125th | | Land & Homes Group | $83k |
| 1126th | | Maximus Resources | $83k |
1328 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Person Activity
| REMUNERATION UPDATE: Non-Executive Director, LBT Innovations | 13 Nov 2020 |
| NEW ROLE: Non-Executive Director, LBT Innovations | 03 Nov 2020 |
Related Information
Positions - Previous
| Position | Company | Year | Company's current rank |
|---|---|---|---|
| Non-Executive Director | | 2012 - 2021 | 930 |
| Non-Executive Director | | - |
